Disproportionality Analysis of Lenvatinib-Caused Gastrointestinal Perforation in Cancer Patients: A Pharmacovigilance Analysis Based on the US Food and Drug Administration Adverse Event Reporting System.

Zhou, Jianxing; Wei, Zipeng; Zheng, You; Xie, Helin; Cao, Wanxia; Cai, Xinying; Huang, Jialin; Wu, Xuemei

Zhou, Jianxing; Wei, Zipeng; Zheng, You; Xie, Helin; Cao, Wanxia; Cai, Xinying; Huang, Jialin; Wu, Xuemei.

Afiliación

Zhou J; Department of Pharmacy, Fujian Medical University Union Hospital, Fuzhou, Fujian, China.
Wei Z; School of Pharmacy, Fujian Medical University, Fuzhou, Fujian, China.
Zheng Y; Department of Pharmacy, Fujian Medical University Union Hospital, Fuzhou, Fujian, China.
Xie H; School of Pharmacy, Fujian Medical University, Fuzhou, Fujian, China.
Cao W; Department of Pharmacy, Fujian Medical University Union Hospital, Fuzhou, Fujian, China.
Cai X; School of Pharmacy, Fujian Medical University, Fuzhou, Fujian, China.
Huang J; Department of Pharmacy, Fujian Medical University Union Hospital, Fuzhou, Fujian, China.
Wu X; School of Pharmacy, Fujian Medical University, Fuzhou, Fujian, China.

J Clin Pharmacol ; 63(10): 1133-1140, 2023 10.

Article en En | MEDLINE | ID: mdl-37474123

Asunto(s)

Efectos Colaterales y Reacciones Adversas Relacionados con Medicamentos; Neoplasias Hepáticas; Quinolinas; Adulto; Anciano; Persona de Mediana Edad; Estados Unidos/epidemiología; Humanos; United States Food and Drug Administration; Farmacovigilancia; Quinolinas/efectos adversos; Bases de Datos Factuales; Sistemas de Registro de Reacción Adversa a Medicamentos

Palabras clave

FAERS database; cancer treatment; gastrointestinal perforation; lenvatinib; pharmacovigilance

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Contexto en salud: 6_ODS3_enfermedades_notrasmisibles Problema de salud: 6_digestive_diseases / 6_liver_cancer Asunto principal: Quinolinas / Efectos Colaterales y Reacciones Adversas Relacionados con Medicamentos / Neoplasias Hepáticas Tipo de estudio: Prognostic_studies Límite: Adult / Aged / Humans / Middle aged País/Región como asunto: America do norte Idioma: En Revista: J Clin Pharmacol Año: 2023 Tipo del documento: Article País de afiliación: China

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google